News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
709,070 Results
Type
Article (39779)
Company Profile (712)
Press Release (668564)
Multimedia
Podcasts (117)
Webinars (26)
Section
Business (202056)
Career Advice (2359)
Deals (36761)
Drug Delivery (144)
Drug Development (79849)
Employer Resources (173)
FDA (16277)
Job Trends (15239)
News (341994)
Policy (30891)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (1898)
Academic (1)
Accelerated approval (43)
Adcomms (24)
Allergies (172)
Alliances (48512)
ALS (212)
Alzheimer's disease (1765)
Antibody-drug conjugate (ADC) (462)
Approvals (16631)
Artificial intelligence (702)
Autoimmune disease (299)
Automation (52)
Bankruptcy (380)
Best Places to Work (11309)
BIOSECURE Act (23)
Biosimilars (218)
Biotechnology (441)
Bladder cancer (186)
Brain cancer (69)
Breast cancer (703)
Cancer (5700)
Cardiovascular disease (480)
Career advice (1984)
Career pathing (45)
CAR-T (335)
CDC (40)
Celiac Disease (2)
Cell therapy (916)
Cervical cancer (45)
Clinical research (69595)
Collaboration (2156)
Company closure (7)
Compensation (1389)
Complete response letters (95)
COVID-19 (2598)
CRISPR (112)
C-suite (1171)
Cystic fibrosis (156)
Data (7737)
Decentralized trials (3)
Denatured (16)
Depression (174)
Dermatology (78)
Diabetes (567)
Diagnostics (7078)
Digital health (55)
Diversity (7)
Diversity, equity & inclusion (40)
Drug discovery (333)
Drug pricing (214)
Drug shortages (32)
Duchenne muscular dystrophy (284)
Earnings (89272)
Editorial (69)
Employer branding (24)
Employer resources (153)
Events (119603)
Executive appointments (1128)
FDA (19974)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (16)
Frontotemporal dementia (33)
Funding (1737)
Gene editing (248)
Generative AI (64)
Gene therapy (739)
GLP-1 (1111)
Government (3735)
Grass and pollen (8)
Guidances (399)
Healthcare (17535)
HIV (80)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (99)
Immunology and inflammation (314)
Immuno-oncology (99)
Indications (188)
Infectious disease (2941)
Inflammatory bowel disease (225)
Inflation Reduction Act (14)
Influenza (137)
Intellectual property (293)
Interviews (465)
IPO (17463)
IRA (52)
Job creations (4298)
Job search strategy (1612)
JPM (65)
Kidney cancer (19)
Labor market (96)
Layoffs (651)
Leadership (46)
Legal (7809)
Liver cancer (98)
Longevity (29)
Lung cancer (745)
Lymphoma (406)
Machine learning (59)
Management (62)
Manufacturing (1072)
MASH (194)
Medical device (14401)
Medtech (14524)
Mergers & acquisitions (20549)
Metabolic disorders (1522)
mRNA (225)
Multiple sclerosis (189)
NASH (21)
Neurodegenerative disease (434)
Neuropsychiatric disorders (118)
Neuroscience (3320)
Neurotech (1)
NextGen: Class of 2026 (6326)
Non-profit (2950)
Now hiring (78)
Obesity (735)
Opinion (339)
Ovarian cancer (211)
Pain (256)
Pancreatic cancer (295)
Parkinson's disease (363)
Partnered (35)
Patents (608)
Patient recruitment (692)
Peanut (64)
People (60637)
Pharmaceutical (127)
Pharmacy benefit managers (33)
Phase 1 (21906)
Phase 2 (31011)
Phase 3 (22941)
Pipeline (8522)
Policy (316)
Postmarket research (2048)
Preclinical (9004)
Press Release (67)
Prostate cancer (293)
Psychedelics (64)
Radiopharmaceuticals (340)
Rare diseases (1109)
Real estate (5969)
Recruiting (73)
Regulatory (24671)
Reports (48)
Research institute (1871)
Resumes & cover letters (377)
Rett syndrome (35)
RNA editing (22)
RSV (89)
Schizophrenia (186)
Series A (309)
Series B (223)
Service/supplier (26)
Sickle cell disease (114)
Special edition (29)
Spinal muscular atrophy (166)
Sponsored (45)
Startups (3979)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (100)
The Weekly (99)
Vaccines (1110)
Venture capital (116)
Weight loss (493)
Women's health (111)
Worklife (23)
Date
Today (219)
Last 7 days (945)
Last 30 days (3522)
Last 365 days (31140)
2026 (12249)
2025 (31053)
2024 (36256)
2023 (41068)
2022 (51942)
2021 (55930)
2020 (53193)
2019 (44603)
2018 (33924)
2017 (33526)
2016 (32175)
2015 (37771)
2014 (30308)
2013 (25016)
2012 (26662)
2011 (26899)
2010 (24434)
Location
Africa (766)
Alabama (99)
Alaska (7)
Arizona (281)
Arkansas (13)
Asia (43343)
Australia (7047)
California (13345)
Canada (3732)
China (1399)
Colorado (563)
Connecticut (587)
Delaware (403)
Europe (95825)
Florida (1942)
Georgia (417)
Hawaii (4)
Idaho (61)
Illinois (993)
India (95)
Indiana (621)
Iowa (25)
Japan (510)
Kansas (130)
Kentucky (52)
Louisiana (36)
Maine (83)
Maryland (1498)
Massachusetts (9797)
Michigan (376)
Minnesota (730)
Mississippi (7)
Missouri (152)
Montana (35)
Nebraska (27)
Nevada (141)
New Hampshire (87)
New Jersey (3539)
New Mexico (32)
New York (3439)
North Carolina (1785)
North Dakota (10)
Northern California (6677)
Ohio (383)
Oklahoma (20)
Oregon (49)
Pennsylvania (2653)
Puerto Rico (30)
Rhode Island (52)
South America (1147)
South Carolina (83)
South Dakota (2)
Southern California (5165)
Tennessee (188)
Texas (2103)
United States (47058)
Utah (389)
Vermont (1)
Virginia (323)
Washington D.C. (82)
Washington State (1086)
West Virginia (4)
Wisconsin (134)
Wyoming (2)
709,070 Results for "general electric company".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GTCR Completes Acquisition of Zentiva, a Leading European Generics Pharmaceutical Company
April 9, 2026
·
5 min read
Press Releases
Delos Capital and AP Biosciences Inc. Launch Collaboration to Create New Biotech Companies Focused on Next-Generation Antibodies
May 12, 2026
·
3 min read
Patents
Pfizer settles with generic drugmakers to protect blockbuster drug until 2031
The settlements delay the entry of generic copies of Pfizer’s Vyndamax by almost three years, stabilizing sales of a drug that generated $3.8 billion in the U.S. last year.
April 29, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Apotex becomes the first Canadian‑based pharmaceutical company to receive Health Canada approval for a generic equivalent of Ozempic®
May 4, 2026
·
3 min read
Press Releases
Mitsubishi Electric and Indian Institute of Technology Hyderabad Sign MOU to Strengthen Industry-Academia Collaboration
February 12, 2026
·
1 min read
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.
April 28, 2026
·
2 min read
·
Tristan Manalac
GLP-1
Generic of Novo’s GLP-1 arrives in Canada, a ‘test case for the world’
Analysts will be watching as a generic version of semaglutide—marketed by Novo Nordisk as Wegovy for weight loss—launches in Canada as a test case for future price erosion in the U.S.
April 29, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030
March 10, 2026
·
8 min read
Job Trends
10 Companies Hiring in Texas Now
Looking for a biopharma job in Texas? Check out the
BioSpace
list of 10 companies hiring life sciences professionals like you.
April 8, 2026
·
1 min read
·
Angela Gabriel
IPO
Generate Arrives on Nasdaq Ready To Finally Show the World AI-Powered Medicines
Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.
March 2, 2026
·
3 min read
·
Annalee Armstrong
1 of 70,907
Next
